IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biodexa Pharmaceuticals (BDRX)

CUSIP: 59564R880 | US | Healthcare · Biotechnology | Micro Cap | 9 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Rhumbline Advisers3
0.0% of portfolio›$8
StyleTurnoverLocationFiled
Rhumbline Advisers
3$80.0%IndexVery LowBoston, MA2026-08-12